Microsoft hopes AI will find better cancer treatments

Microsoft is also teaming with the Knight Cancer Institute on AI that would personalize those drug mixes on a patient-by-patient basis. They're primarily focused on acute myeloid leukemia, where you might end up battling multiple leukemias at once -- machine learning could identify just what you're dealing with and treat it accordingly. Another effort would lean heavily on computer vision to understand how a tumor is reacting to treatments. Human doctors can easily identify tumors, Microsoft notes, but they can't always tell how tumors are changing or how they're affecting the health of nearby cells. The Redmond crew is even more ambitious than that.